Cargando…
An Atypical Clinical Course of Anti-MDA5 Antibody-positive Interstitial Lung Disease in a Patient with Three Deteriorations in 9 years
Anti-MDA5 antibody-positive patients with clinically amyopathic dermatomyositis (CADM) are at high risk of developing rapidly progressive interstitial lung disease (ILD), which is associated with a high mortality rate. Approximately half of the patients with ILD recover; however, the long-term clini...
Autores principales: | Sato, Yuki, Otsuka, Kojiro, Tamai, Koji, Ono, Yuichiro, Hamaguchi, Yasuhito, Tomii, Keisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348460/ https://www.ncbi.nlm.nih.gov/pubmed/28154280 |
Ejemplares similares
-
Primary pulmonary lymphoma mimicking a refractory lung abscess: A case report
por: MATSUMOTO, TAKESHI, et al.
Publicado: (2015) -
The validity and reliability of four-meter gait speed test for stable interstitial lung disease patients: the prospective study
por: Hirabayashi, Ryosuke, et al.
Publicado: (2020) -
Biliary Pneumonia due to the Presence of a Bronchobiliary Fistula
por: Matsumoto, Takeshi, et al.
Publicado: (2017) -
Soluble CD206 levels correlate with disease deterioration and predict prognosis of anti‐MDA5 antibody‐positive dermatomyositis related interstitial lung disease
por: Li, Yan, et al.
Publicado: (2023) -
The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma
por: Sato, Yuki, et al.
Publicado: (2016)